D6R-94419-06257
5 vaccinations
4 coded responses
41 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 917 / CA
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Registered in v-safe
-
2021-02-05
Dose 1 — Moderna
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
-
2021-02-19
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site mass, Injection site pruritus — Feeling: GoodFree text: Developed a red spot at the vaccination site about the size of a quarter. Small itchy lump. Noticed it Saturday February 13. Gone by Monday the 15th. Area is still a little itchy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Survey response — day 21, dose 1MedDRA: Contusion, Pallor, Rash erythematous, Rash pruritic — Feeling: GoodFree text: Developed rash that was 3 inches by four inches. It was quite red like a sunburn. Also slightly itchy. It has since faded to what looks like a pale bruise. No longer itchy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Dose 2 — Moderna
- 2021-03-05
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body achesAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Diarrhea, Abdominal painAdult check-in
-
2021-03-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body achesAdult check-in
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-06-04
- 2021-09-03
-
2021-11-05
Dose 3 — Moderna
- 2022-03-05
-
2022-04-19
Dose 4 — Moderna
- 2022-04-24
- 2022-04-25
- 2022-04-27
- 2022-05-03
- 2022-05-10
- 2022-05-17
- 2022-05-24
- 2022-05-31
- 2022-07-19
-
2022-09-14
Dose 5 — Moderna
- 2022-10-05
- 2022-10-12
- 2022-10-20
- 2022-10-27
-
2022-12-14
Survey response — 3 months, dose 5MedDRA: Adverse reaction, COVID-19, Cough, Nasal congestion, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Throat irritation — Feeling: GoodFree text: Caught Covid in Paris France the end of Oct this year. Very mild. Thought it was alergies. No fever. Slight cough, scratchy throat and stuffy nose. Did not see a doctor. Did home tests until tested negative.MedDRA releases: 2024-11 · check-in free text available
-
2023-03-15
Survey response — 6 months, dose 5MedDRA: COVID-19, SARS-CoV-2 test positive — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Moderna | |
| 2 | 2021-03-05 | Moderna | |
| 3 | 2021-11-05 | Moderna | No |
| 4 | 2022-04-19 | Moderna | No |
| 5 | 2022-09-14 | Moderna | No |
Free text
Release 4 — day 14, dose 1
Symptoms: Developed a red spot at the vaccination site about the size of a quarter. Small itchy lump. Noticed it Saturday February 13. Gone by Monday the 15th. Area is still a little itchy.
Release 4 — day 21, dose 1
Symptoms: Developed rash that was 3 inches by four inches. It was quite red like a sunburn. Also slightly itchy. It has since faded to what looks like a pale bruise. No longer itchy.
Release 12 — 3 months, dose 5
Symptoms: Caught Covid in Paris France the end of Oct this year. Very mild. Thought it was alergies. No fever. Slight cough, scratchy throat and stuffy nose. Did not see a doctor. Did home tests until tested negative.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse reaction | · | · | ✓ |
| SD | Contusion | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site mass | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pallor | ✓ | ✓ | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SD | Rash pruritic | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release